Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DEFB1 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic results in decreased expression of DEFB1 mRNA | decreases expression | 18511430
|
D001151 |
Arsenic |
Arsenic results in decreased expression of DEFB1 protein | decreases expression | 18511430
|
D019324 |
beta-Naphthoflavone |
beta-Naphthoflavone results in decreased expression of DEFB1 mRNA | decreases expression | 19737606
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of DEFB1 mRNA | increases expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of DEFB1 mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of DEFB1 mRNA | increases expression | 19638242
|
D004391 |
Dust |
Dust results in decreased expression of DEFB1 mRNA | decreases expression | 17805423
|
D005480 |
Flurbiprofen |
Flurbiprofen results in decreased expression of DEFB1 mRNA | decreases expression | 16949054
|
C058305 |
phenethyl isothiocyanate |
phenethyl isothiocyanate results in increased expression of DEFB1 mRNA | increases expression | 17616710
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of DEFB1 mRNA | increases expression | 20059764 18301758
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of DEFB1 mRNA] | increases expression|increases reaction | 20059764
|
C025299 |
polyphenols |
polyphenols results in decreased expression of DEFB1 mRNA | decreases expression | 16293270
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of DEFB1 mRNA | decreases expression | 17350061
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of DEFB1 mRNA | decreases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.68 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.20 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.00 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
11.47 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
11.47 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.47 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
17.99 | 18056438 19052882 17162532 16434500 17620307 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
17.99 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
17.99 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Flurbiprofen |
5.14 | 10680582 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.83 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
14.25 | 17306315 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
14.25 | 17306315 16712894 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.18 | 19183758 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.89 | 12569548 16835338 18414634 16251483 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.29 | 12928151 19371607 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.04 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.04 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.80 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.80 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.80 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.63 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
4.74 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.74 | 17978847 20101231 19539802 18056438 18210153 20512989 18506893 20432363 16328049 20084675 3084413 17162532 16502159 10737359 19701751 18971187 18788625 11831363 19919837 16681979 19052882 21159647 20727157 18691550 16878318 3581430 20514400 19335982 16288022 19107877 17173139 18785209 17138121 16807293 19171122 18665156 17055752 20007298 16569478 20524982 16698587 19383236 20214788 16779866 19208518 18393292 10672840 19418558 16935385 18494052 16540662 19519916 16830150 17761372 20935162 19822196 17428255 19394651 18978308 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.74 | 17306315 15276417 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
7.69 | 18922899 17687452 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.69 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.69 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.15 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 16120746 18850075 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.50 | 17938729 19152805 15738583 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.38 | 18022660 16973168 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.51 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.51 | 7505956 21159647 17174075 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
11.51 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.57 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.57 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.96 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.96 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D003093 |
Colitis, Ulcerative |
|
phenethyl isothiocyanate |
3.67 | 20423518 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.68 | 16293270 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.46 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.28 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.28 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.41 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
6.41 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.41 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.81 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.81 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 16714409 15322242 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 9294722 10568697 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.25 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.02 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.53 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
13.53 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.53 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.83 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.83 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.69 | 6392382 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.80 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.58 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.58 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.58 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.61 | 19176532 19772884 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.61 | 12621046 16120746 15340226 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.22 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 8697196 15340226 16959395 18606429 16354765 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.26 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.53 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
8.75 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.75 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.75 | 18670907 18850075 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.69 | 16093927 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.04 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
12.39 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flurbiprofen |
12.39 | 11099482 |
MESH:D007249 |
Inflammation |
|
polyphenols |
12.39 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
12.39 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.68 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.11 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.16 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.16 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.80 | 12371664 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.60 | 17339181 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.87 | 18665156 18407596 18522880 20032147 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.16 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.16 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
6.81 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.81 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
6.81 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
22.38 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
22.38 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
22.38 | 21295105 19389873 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
22.38 | 18978307 20101389 9163691 19255062 19812893 19996281 20501860 21071580 19850985 20583210 20434301 18977376 21047994 19642983 18644402 15175105 20405173 19254457 20118626 18648771 21167192 19294768 19833225 18754104 19090486 19426721 20452335 21278145 19256749 19499222 19073162 19638242 20492335 20137499 16942905 12771043 15885732 19690152 19551842 12112319 10737359 19427195 2422723 2862719 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
22.38 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
22.38 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
22.38 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
10.15 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.15 | 18282651 19004024 19519916 17854601 18308698 3124819 19009564 9362446 16267830 17942915 18775883 17174075 19539802 16842330 18544905 2563599 21159647 18093689 18079962 18253720 18164116 19126423 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.15 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.22 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
6.68 | 17306315 19168569 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.68 | 17053015 6695378 18520028 20064080 20464547 20135361 18569708 20869020 18816296 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.68 | 21163286 20970405 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.68 | 17306315 17077188 19931552 15276417 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.68 | 11884234 19555203 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.04 | 16487513 19082730 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.25 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.61 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.17 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
9.22 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.22 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.01 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.59 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.43 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.43 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.43 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.77 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.36 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.31 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.63 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.63 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.41 | 20387270 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.46 | 17056641 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.25 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.83 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
5.11 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.11 | 15276417 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.45 | 16540662 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.27 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.11 | 16905509 15371236 6392382 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.19 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.19 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.31 | 11399792 11896295 11222880 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17013881 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.14 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.14 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flurbiprofen |
2.14 | 17409433 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.14 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
4.09 | 21343184 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.42 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.76 | 17050553 6392382 17938729 16353154 17453740 16759981 15952646 19834688 17548696 16702368 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
13.87 | 17029826 15504454 17976673 19538983 16251483 17050553 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.87 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.87 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.87 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.86 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.35 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.35 | 18456281 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.39 | 17997062 |
MESH:D013733 |
Testicular Diseases |
|
phenethyl isothiocyanate |
5.06 | 15864552 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.04 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
8.54 | 11144890 19322015 17306315 17976673 19429237 15987713 18640142 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.54 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.54 | 16452187 16712894 17306315 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.84 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
12.24 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
12.24 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |